Loading news...
Summary HARBOR CAPITAL ADVISORS, INC. reduced its stake in Ascendis Pharma AS (ASND) by 1.17%, selling 269 shares and holding 22,734 shares valued at a
– Once-weekly TransCon ® CNP and TransCon ® hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks – Annualized growth velocity (AGV) exceeded the 97th-percentile of average stature children – ACH height Z-score improvements indicated a tripling of efficacy compared to TransCon CNP monotherapy – Combination therapy demonstrated benefits beyond linear growth with improvements in body proportionality and arm span, aligning with the increase in linear growth – All children completed 52 weeks of treatment and remain on therapy in COACH as of today – Combination therapy was generally well tolerated, with generally mild treatment-emergent adverse events (TEAEs), consistent with TransCon CNP and TransCon hGH monotherapies – Ascendis to host conference call today at 4:30pm ET COPENHAGEN, Denmark, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced topline results from Week 52 of COACH, the first Phase 2 clinical trial to evaluate combination therapy with once-weekly TransCon CNP (navepegritide) and once-weekly TransCon hGH (lonapegsomatropin) in children with achondroplasia. At Week 52, combination therapy showed durable growth without compromising safety or tolerability.
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, “ACH”, effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This rele.
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (the “Company”) announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc. “Today's announcement marks an inflection point in the strategic transformation of Owens & Minor into Accendra Health, a leading nationwide pure play home based care platform. The completio.
LONDON, UK / ACCESS Newswire / December 31, 2025 / Orosur Mining Inc. ("Orosur" or "the Company") (AIM:OMI)(TSXV:OMI), a minerals explorer and developer with projects in Colombia and Argentina, advises that, following the Admission of 666,664 common shares of no par value ("Common Shares") on 16 December 2025 pursuant to the exercise of options by consultants of the Company, as announced on 15 December 2025, the Company has 392,689,176 Common Shares in issue. There were no warrants exercised and therefore no Common Shares issued during December from the Company's block listing.
Owens and Minor (NYSE: OMI - Get Free Report) and Senestech (NASDAQ: SNES - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Volatility and Risk Owens and Minor has
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) (“the Company”) today announced that it will change its name to Accendra Health, Inc. with an anticipated effective date of December 31, 2025. The name change affects only the name of the parent corporation and is intended to better reflect the Company's strategic direction and future organizational focus as a leader in the home-based care market. The Company will continue to use and operate under the Apria and Byram Healthcare.
Owens & Minor, Inc. (OMI) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) announced today that members of its management team are scheduled to participate in two upcoming investor conferences. Citi 2025 Global Healthcare Conference On Tuesday, December 2, 2025, Ed Pesicka, the Company's President and Chief Executive Officer, and Will Parrish, the Company's Vice President of Strategy, Corporate Development, & Investor Relations, are scheduled to participate in a fireside chat at 2:30 P.M. ET and h.
Orosur Mining Inc. -Notice of Annual and Special Meeting LONDON, UK / ACCESS Newswire / November 21, 2025 / Orosur Mining Inc. ("Orosur" or "the Company") (TSX-V:OMI)(AIM:OMI) the minerals explorer and developer currently operating in Colombia and Argentina announces that copies of the Company's Notice of Annual and Special Meeting ("AGM"), including the Management Information Circular and proxy forms have been posted to shareholders. Copies are also available on the website at: https://www.orosur.ca A link to the PDF version of the Notice of AGM is also available here: http://www.rns-pdf.londonstockexchange.com/rns/4570I_1-2025-11-20.pdf The AGM will be held on 17 th December 2025 at 12.30pm GMT (UK local time) at the offices of SP Angel Corporate Finance LLP, Prince Frederick House, 35-39 Maddox Street, London, W1S 2PP, England.
Exercise of RSUs and options LONDON, UK / ACCESS Newswire / November 4, 2025 / Orosur Mining Inc. ("Orosur" or the "Company") (TSXV:OMI)(AIM:OMI) announces the following: The Company has issued 4,358,332 Common Shares ("Shares") representing 1.13% of the Company's current issued share capital, following the exercise of 3,123,332 RSUs and 1,280,000 options by directors and consultants of the Company. All of the directors will be retaining their Shares and not selling after exercise.
Owens & Minor, Inc. ( OMI ) Q3 2025 Earnings Call October 30, 2025 5:00 PM EDT Company Participants Will Parrish Edward Pesicka - President, CEO & Director Jonathan Leon - Executive VP, CFO & Corporate Treasurer Perry Bernocchi - Executive VP & CEO of Patient Direct Segment Conference Call Participants Daniel Christopher Clark - Leerink Partners LLC, Research Division Kevin Caliendo - UBS Investment Bank, Research Division Daniel Grosslight - Citigroup Inc., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to Owens & Minor's Third Quarter 2025 Earnings Conference Call.
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. “Our recent announcement on the sale of our Products & Healthcare Services segment is another meaningful step in our strategy to pivot our focus to th.
Orosur Mining Inc (AIM:OMI, TSX-V:OMI) shares climbed 5% to 22p after the company announced high-grade gold intercepts and an expanding exploration footprint across its projects in Colombia and Argentina. At the Pepas prospect within the Anzá Project in Colombia, assays from three new holes returned standout results, including 112 metres at 5.25g/t gold from surface in hole PEP066.
VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Owens and Minor, Inc. (NYSE: OMI) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 36,528 shares of the company's stock, valued at approximately $332,000. A
LONDON, UK / ACCESS Newswire / October 24, 2025 / Orosur Mining Inc. ("Orosur" or "the Company") (TSX-V:OMI)(AIM:OMI) announces its audited results for the first quarter ended August 31, 2025. All dollar figures are stated in thousands of US$ unless otherwise noted.
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LONDON, UK / ACCESS Newswire / October 16, 2025 / Orosur Mining Inc (TSXV:OMI)(AIM:OMI), the mineral explorer and developer with current operations in Columbia, Argentina and Nigeria, is pleased to announce that following an Investor Presentation via the Investor Meet Company platform given on 15th October, the presentation can be viewed on the Company's website using the following link: https://www.orosur.ca/investors/presentations/ For further information visit www.orosur.ca, follow on X @orosurm or contact: Orosur Mining Inc. Louis Castro, Executive Chairman,Brad George, CEO info@orosur.ca Tel: +1 (778) 373-0100 SP Angel Corporate Finance LLP - Nomad & Joint Broker Jeff Keating / Jen Clarke / Devik MehtaTel: +44 (0)20 3470 0470 Turner Pope Investments (TPI) Ltd - Joint Broker Andy Thacker/James PopeTel: +44 (0)20 3657 0050 Flagstaff Strategic and Investor Communications Tim ThompsonMark EdwardsFergus Mellon orosur@flagstaffcomms.com Tel: +44 (0)207 129 1474 This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply.
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All intere.
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.